Daily Archives: 15, October 2024

ANDRITZ and Cell Impact Join Forces to Supercharge High-Speed Bipolar Flow Plate Production

(IN BRIEF) Cell Impact has partnered with international technology group ANDRITZ to enhance large-scale production of bipolar flow plates for fuel cells and electrolyzers. The collaboration focuses on integrating ANDRITZ’s new Soucell welding system, capable of welding one bipolar plate … Read the full press release

Boehringer Ingelheim and WHO Foundation Collaborate to Boost Global Healthcare Access and Suicide Prevention Efforts

(IN BRIEF) Boehringer Ingelheim and the WHO Foundation have partnered to promote equitable healthcare access and suicide prevention, with a focus on vulnerable communities in the Americas. Boehringer Ingelheim pledged $5 million to support WHO’s 2025–2028 General Program of Work … Read the full press release

ESET Secures Strategic Leadership in 2024 EPR Report, Excels in Threat Detection and Response

(IN BRIEF) ESET has been recognized as a Strategic Leader for the fourth time in the AV-Comparatives 2024 Endpoint Prevention and Response (EPR) Comparative Report. ESET PROTECT Enterprise achieved the highest score for Prevention and Response, detecting 98% of threats … Read the full press release

New Guarantee Agreement Empowers Danish SMEs to Pursue Green Investments

(IN BRIEF) The European Investment Fund (EIF) and Ringkjøbing Landbobank have entered a groundbreaking guarantee agreement to facilitate DKK 320 million in funding for green investments by Danish small and medium-sized enterprises (SMEs) and mid-caps. Supported by the European Commission’s … Read the full press release

Strengthening Collaboration: CEB and EIB Group Unite to Tackle Social Challenges in Europe

(IN BRIEF) On October 14, 2024, the Council of Europe Development Bank (CEB) and the EIB Group, which comprises the European Investment Bank (EIB) and the European Investment Fund (EIF), convened in Paris to enhance collaboration in tackling the growing … Read the full press release

EIB Global Invests €2 Million in Vaccine Development at Akagera Medicines in Rwanda

(IN BRIEF) The European Investment Bank (EIB Global) has committed €2 million to support Akagera Medicines Africa Limited in Rwanda, facilitating the early-stage development of vaccines for infectious diseases, including tuberculosis, HIV, Ebola, and Lassa fever. This funding aims to … Read the full press release